Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ewelina Kluza"'
Autor:
Ewelina Kluza, Annelie Shami, Thijs J. Beldman, Anita E. Grootemaat, Willem J. M. Mulder, Esther Lutgens, Stephan Huveneers, Nicole N. van der Wel, Tsveta S. Malinova, Edwin R. Scholl, Isabel Gonçalves
Publikováno v:
Atherosclerosis, 339, 35-45. Elsevier Ireland Ltd
Atherosclerosis, 339, 35-45
Atherosclerosis, 339, pp. 35-45
Atherosclerosis, 339, 35-45
Atherosclerosis, 339, pp. 35-45
Contains fulltext : 245675.pdf (Publisher’s version ) (Open Access) BACKGROUND AND AIMS: The endothelium plays a major role in atherosclerosis, yet the endothelial plaque surface is a largely uncharted territory. Here we hypothesize that atheroscle
Autor:
Anita E. Grootemaat, Stephan Huveneers, Ron A. Hoebe, Saskia van der Velden, Menno P.J. de Winther, Aresh L. S. Misiak, Nicole N. van der Wel, Emilie C B Desclos, Linda Beckers, Cindy P. A. A. van Roomen, Tsveta S. Malinova, Henk A. van Veen, Thijs J. Beldman, Annette E. Neele, Przemyslaw M. Krawczyk, Esther Lutgens, Ewelina Kluza, Willem J. M. Mulder, Judith C. Sluimer
Publikováno v:
ACS Nano, 13(12), 13759-13774. American Chemical Society
ACS nano, 13(12), 13759-13774. American Chemical Society
ACS Nano
ACS nano, 13(12), 13759-13774. American Chemical Society
ACS Nano
Atherosclerosis is associated with a compromised endothelial barrier, facilitating the accumulation of immune cells and macromolecules in atherosclerotic lesions. In this study, we investigate endothelial barrier integrity and the enhanced permeabili
Autor:
Ewelina Kluza, Floor Ummels, Eveline G. Nugraha, Stijn R. J. Hofstraat, Thijs J. Beldman, Tom Anbergen, Zahi A. Fayad, Roy van der Meel, Mirre M. Trines, David P. Schrijver, Anne de Dreu, Jeroen Deckers, Willem J. M. Mulder, Rutger J. Röring, Koen de Bruin, Abraham J. P. Teunissen, Robby Zwolsman
Publikováno v:
Advanced Therapeutics, 4(8):2100083. Wiley-VCH Verlag
In the slipstream of targeting the adaptive immune system, innate immunotherapy strategies are being developed. In this context, technologies based on natural carrier vehicles that inherently interact with the innate immune system, are increasingly b
Autor:
Yu-Xiang Ye, Esther Lutgens, Zahi A. Fayad, Gerard Pasterkamp, Niels P. Riksen, Abraham J. P. Teunissen, Francois Fay, Matthias Nahrendorf, Joost Malkus, Ewelina Kluza, Leo A. B. Joosten, Raphaël Duivenvoorden, Marnix Lameijer, Mihai G. Netea, Roy van der Meel, Gregory R. Wojtkiewicz, Nils Rother, Thijs J. Beldman, Emma D. Klein, Brenda L. Sanchez-Gaytan, Carlos Pérez-Medina, Sheqouia A. Nauta, Mandy M. T. van Leent, Arjan Boltjes, Willem J. M. Mulder, Bowen Zhang, Bin Zhang, Filip K. Swirski, Yang Li, Siroon Bekkering, Yohana C. Toner, Xianxiao Zhou, Edward A. Fisher
Publikováno v:
Sci Transl Med
Science Translational Medicine, 13(584):eabe1433. American Association for the Advancement of Science (AAAS)
Science Translational Medicine, 13
Science Translational Medicine, 13, 584
Science translational medicine, 13(584):eabe1433. American Association for the Advancement of Science
Science Translational Medicine, 13(584):eabe1433. American Association for the Advancement of Science (AAAS)
Science Translational Medicine, 13
Science Translational Medicine, 13, 584
Science translational medicine, 13(584):eabe1433. American Association for the Advancement of Science
Macrophages play a central role in the pathogenesis of atherosclerosis. The inflammatory properties of these cells are dictated by their metabolism, of which the mechanistic target of rapamycin (mTOR) signaling pathway is a key regulator. Using myelo
Autor:
Willem J. M. Mulder, Carlos Pérez-Medina, Roy van der Meel, Abraham J. P. Teunissen, Ewelina Kluza
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Instituto de Salud Carlos III (ISCIII)
Nanomedicine approaches can effectively modulate the biodistribution and bioavailability of therapeutic agents, improving their therapeutic index. However, despite the ever-increasing amount of literature reporting on preclinical nanomedicine, the nu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dba9daad78cd09d6c4eb1ff2f0c1c798
https://hdl.handle.net/20.500.12105/12601
https://hdl.handle.net/20.500.12105/12601
Autor:
Elena Kartvelishvily, Jun Tang, Jacqueline Deichmöller, Nicole N. van der Wel, Menno P.J. de Winther, Fortune Kohen, Carlos Pérez-Medina, Ewelina Kluza, Benjamin Born, Zahi A. Fayad, Max L. Senders, Ron A. Hoebe, Francois Fay, Michal Neeman, Thomas Reiner, Thijs J. Beldman, Willem J. M. Mulder, Amr Alaarg, Yiming Zhao, Claudia Calcagno, Esther Lutgens, Emilie C B Desclos
Publikováno v:
ACS Nano, 11(6), 5785-5799. American Chemical Society
ACS nano, 11(6), 5785-5799. American Chemical Society
ACS Nano
ACS nano, 11(6), 5785-5799. American Chemical Society
ACS Nano
Hyaluronan is a biologically active polymer, which can be formulated into nanoparticles. In our study, we aimed to probe atherosclerosis-associated inflammation by using hyaluronan nanoparticles and to determine whether they can ameliorate atheroscle
Autor:
Ewelina Kluza
Publikováno v:
Atherosclerosis, 310, 91-92. Elsevier Ireland Ltd
Autor:
Ewelina Kluza, Monique Maas, Cécile R. L. P. N. Jeukens, Jean-Paul J. E. Kleijnen, Axel zur Hausen, Robert G. Riedl, Regina G. H. Beets-Tan, Dorit Rennspiess, Geerard L. Beets, Milou H. Martens
Publikováno v:
European Radiology, 26(5), 1311-1319. Springer, Cham
To evaluate the MRI macroscopic and microscopic parameters of mesorectal vasculature in rectal cancer patients. Thirteen patients with rectal adenocarcinoma underwent a dynamic contrast-enhanced MRI at 1.5 T using a blood pool agent at the primary st
Autor:
Mandy M. T. van Leent, Jazz Munitz, Yiming Zhao, Georgios Soultanidis, Anu E. Meerwaldt, Rick M. Dijkhuizen, Esther M. van Leeuwen, Jordi Ochando, Mihai G. Netea, Anna Vera D Verschuur, Thomas Reiner, Yohana C. Toner, Eva Zupančič, Raphaël Duivenvoorden, Hidde L. Ploegh, Sjoerd Hak, Alexander Rialdi, Leo A. B. Joosten, Lisa Willemsen, Ernesto Guccione, Willem J. M. Mulder, Denis Torre, Arjan W. Griffioen, Mohammad Rashidian, Vera P. Mourits, Zahi A. Fayad, Bram Priem, Roderick S. Oosterwijk, Abraham J. P. Teunissen, Emma D. Klein, Paul H. H. Bomans, Karen A.M. de Jong, Heiner Friedrich, Jose Javier Bravo-Cordero, Julie Di Martino, Alexandros Marios Sofias, Claudia Calcagno, Andrea van Elsas, Ewelina Kluza, Geoffrey Prévot, Carlos Pérez-Medina, Nico A. J. M. Sommerdijk, Menno P.J. de Winther, Sheqouia A. Nauta, Elizabeth L. Fisher
Publikováno v:
Cell, 183(3), 786-801.e19. Cell Press
Priem, B, van Leent, M M T, Teunissen, A J P, Sofias, A M, Mourits, V P, Willemsen, L, Klein, E D, Oosterwijk, R S, Meerwaldt, A E, Munitz, J, Prévot, G, Vera Verschuur, A, Nauta, S A, van Leeuwen, E M, Fisher, E L, de Jong, K A M, Zhao, Y, Toner, Y C, Soultanidis, G, Calcagno, C, Bomans, P H H, Friedrich, H, Sommerdijk, N, Reiner, T, Duivenvoorden, R, Zupančič, E, Di Martino, J S, Kluza, E, Rashidian, M, Ploegh, H L, Dijkhuizen, R M, Hak, S, Pérez-Medina, C, Bravo-Cordero, J J, de Winther, M P J, Joosten, L A B, van Elsas, A, Fayad, Z A, Rialdi, A, Torre, D, Guccione, E, Ochando, J, Netea, M G, Griffioen, A W & Mulder, W J M 2020, ' Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition ', Cell, vol. 183, no. 3, pp. 786-801.e19 . https://doi.org/10.1016/j.cell.2020.09.059
Cell
Cell, 183, 3, pp. 786-801.e19
Cell, 183, 786-801.e19
Priem, B, van Leent, M M T, Teunissen, A J P, Sofias, A M, Mourits, V P, Willemsen, L, Klein, E D, Oosterwijk, R S, Meerwaldt, A E, Munitz, J, Prévot, G, Vera Verschuur, A, Nauta, S A, van Leeuwen, E M, Fisher, E L, de Jong, K A M, Zhao, Y, Toner, Y C, Soultanidis, G, Calcagno, C, Bomans, P H H, Friedrich, H, Sommerdijk, N, Reiner, T, Duivenvoorden, R, Zupančič, E, Di Martino, J S, Kluza, E, Rashidian, M, Ploegh, H L, Dijkhuizen, R M, Hak, S, Pérez-Medina, C, Bravo-Cordero, J J, de Winther, M P J, Joosten, L A B, van Elsas, A, Fayad, Z A, Rialdi, A, Torre, D, Guccione, E, Ochando, J, Netea, M G, Griffioen, A W & Mulder, W J M 2020, ' Trained Immunity-Promoting Nanobiologic Therapy Suppresses Tumor Growth and Potentiates Checkpoint Inhibition ', Cell, vol. 183, no. 3, pp. 786-801.e19 . https://doi.org/10.1016/j.cell.2020.09.059
Cell
Cell, 183, 3, pp. 786-801.e19
Cell, 183, 786-801.e19
Trained immunity, a functional state of myeloid cells, has been proposed as a compelling immune-oncological target. Its efficient induction requires direct engagement of myeloid progenitors in the bone marrow. For this purpose, we developed a bone ma
Autor:
Raphaël Duivenvoorden, Rob J.W. Arts, Zahi A. Fayad, Peter Boros, Susanne Kossatz, Patricia Conde, Christian Weber, Ewelina Kluza, Ivan Marazzi, Jordi Ochando, Gerry A. F. Nicolaes, Maria Gonzalez-Perez, Marnix Lameijer, Manisha Brahmachary, Regine J. Dress, Carlos Pérez-Medina, Alexander Rialdi, Matthias Nahrendorf, Francois Fay, Filip K. Swirski, García M, Florent Ginhoux, Fadi Salem, Willem J. M. Mulder, Mandy M. T. van Leent, Claudia Calcagno, Gustav J. Strijkers, Esther Lutgens, Thomas Reiner, Brenda L. Sanchez-Gaytan, Mounia S. Braza, Mihai G. Netea, Edward A. Fisher
Publikováno v:
Repisalud
Instituto de Salud Carlos III (ISCIII)
Immunity, 49, 819-828.e6
Immunity, 49(5), 819-828.e6. Cell Press
Immunity, 49, 5, pp. 819-828.e6
Instituto de Salud Carlos III (ISCIII)
Immunity, 49, 819-828.e6
Immunity, 49(5), 819-828.e6. Cell Press
Immunity, 49, 5, pp. 819-828.e6
Inducing graft acceptance without chronic immunosuppression remains an elusive goal in organ transplantation. Using an experimental transplantation mouse model, we demonstrate that local macrophage activation through dectin-1 and toll-like receptor 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63120dead52d0295a3a0647fba978832
http://hdl.handle.net/20.500.12105/10393
http://hdl.handle.net/20.500.12105/10393